Skip to main content
PMC home page
The Journal of Experimental Medicine logoLink to The Journal of Experimental Medicine
. 1992 Dec 1;176(6):1605–1609. doi: 10.1084/jem.176.6.1605

A severe combined immunodeficient (SCID) mouse model for infection with Entamoeba histolytica

PMCID: PMC2119462  PMID: 1460420

Abstract

We used severe combined immunodeficient (SCID) mice to study resistance to invasive infection with Entamoeba histolytica. Seven of seven SCID mice developed liver abscesses when challenged intrahepatically with virulent HM1:IMSS strain E. histolytica trophozoites. Only one of seven similarly challenged immunocompetent congenic C.B-17 mice developed an abscess. Adoptive transfer of polyclonal rabbit anti-E. histolytica antiserum, but not preimmune rabbit serum, completely protected 7 of 12 SCID mice from intrahepatic challenge with ameba. These results demonstrate that lymphocyte-based immunity is important in protection against amebic liver abscess, and that anti-E. histolytica antibody can protect against amebic infection in this system. The SCID mouse may provide a powerful model for studying the components of protective immunity to invasive amebiasis.

Full Text

The Full Text of this article is available as a PDF (1.7 MB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bancroft G. J., Sheehan K. C., Schreiber R. D., Unanue E. R. Tumor necrosis factor is involved in the T cell-independent pathway of macrophage activation in scid mice. J Immunol. 1989 Jul 1;143(1):127–130. [PubMed] [Google Scholar]
  2. Bos H. J., van de Griend R. J. Virulence and toxicity of axenic Entamoeba histolytica. Nature. 1977 Jan 27;265(5592):341–343. doi: 10.1038/265341a0. [DOI] [PubMed] [Google Scholar]
  3. Bosma G. C., Custer R. P., Bosma M. J. A severe combined immunodeficiency mutation in the mouse. Nature. 1983 Feb 10;301(5900):527–530. doi: 10.1038/301527a0. [DOI] [PubMed] [Google Scholar]
  4. Brandt H., Tamayo R. P. Pathology of human amebiasis. Hum Pathol. 1970 Sep;1(3):351–385. doi: 10.1016/s0046-8177(70)80072-7. [DOI] [PubMed] [Google Scholar]
  5. Butterworth A. E., Sturrock R. F., Houba V., Rees P. H. Antibody-dependent cell-mediated damage to schistosomula in vitro. Nature. 1974 Dec 6;252(5483):503–505. doi: 10.1038/252503a0. [DOI] [PubMed] [Google Scholar]
  6. Custer R. P., Bosma G. C., Bosma M. J. Severe combined immunodeficiency (SCID) in the mouse. Pathology, reconstitution, neoplasms. Am J Pathol. 1985 Sep;120(3):464–477. [PMC free article] [PubMed] [Google Scholar]
  7. Czitrom A. A., Edwards S., Phillips R. A., Bosma M. J., Marrack P., Kappler J. W. The function of antigen-presenting cells in mice with severe combined immunodeficiency. J Immunol. 1985 Apr;134(4):2276–2280. [PubMed] [Google Scholar]
  8. Dean D. A., Wistar R., Murrell K. D. Combined in vitro effects of rat antibody and neutrophilic leukocytes on schistosomula of Schistosoma mansoni. Am J Trop Med Hyg. 1974 May;23(3):420–428. doi: 10.4269/ajtmh.1974.23.420. [DOI] [PubMed] [Google Scholar]
  9. Dharakul T., Rott L., Greenberg H. B. Recovery from chronic rotavirus infection in mice with severe combined immunodeficiency: virus clearance mediated by adoptive transfer of immune CD8+ T lymphocytes. J Virol. 1990 Sep;64(9):4375–4382. doi: 10.1128/jvi.64.9.4375-4382.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Diamond L. S., Harlow D. R., Cunnick C. C. A new medium for the axenic cultivation of Entamoeba histolytica and other Entamoeba. Trans R Soc Trop Med Hyg. 1978;72(4):431–432. doi: 10.1016/0035-9203(78)90144-x. [DOI] [PubMed] [Google Scholar]
  11. George A., Kost S. I., Witzleben C. L., Cebra J. J., Rubin D. H. Reovirus-induced liver disease in severe combined immunodeficient (SCID) mice. A model for the study of viral infection, pathogenesis, and clearance. J Exp Med. 1990 Mar 1;171(3):929–934. doi: 10.1084/jem.171.3.929. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Gold D., Kagan I. G. Susceptibility of various strains of mice to Entamoeba histolytica. J Parasitol. 1978 Oct;64(5):937–938. [PubMed] [Google Scholar]
  13. Holaday B. J., Sadick M. D., Wang Z. E., Reiner S. L., Heinzel F. P., Parslow T. G., Locksley R. M. Reconstitution of Leishmania immunity in severe combined immunodeficient mice using Th1- and Th2-like cell lines. J Immunol. 1991 Sep 1;147(5):1653–1658. [PubMed] [Google Scholar]
  14. Lauzon R. J., Siminovitch K. A., Fulop G. M., Phillips R. A., Roder J. C. An expanded population of natural killer cells in mice with severe combined immunodeficiency (SCID) lack rearrangement and expression of T cell receptor genes. J Exp Med. 1986 Nov 1;164(5):1797–1802. doi: 10.1084/jem.164.5.1797. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Mead J. R., Arrowood M. J., Sidwell R. W., Healey M. C. Chronic Cryptosporidium parvum infections in congenitally immunodeficient SCID and nude mice. J Infect Dis. 1991 Jun;163(6):1297–1304. doi: 10.1093/infdis/163.6.1297. [DOI] [PubMed] [Google Scholar]
  16. Minagawa H., Sakuma S., Mohri S., Mori R., Watanabe T. Herpes simplex virus type 1 infection in mice with severe combined immunodeficiency (SCID). Arch Virol. 1988;103(1-2):73–82. doi: 10.1007/BF01319810. [DOI] [PubMed] [Google Scholar]
  17. Neal R. A., Harris W. G. Proceedings: Attempts to infect inbred strains of rats and mice with Entamoeba histolytica. Trans R Soc Trop Med Hyg. 1975;69(4):429–430. [PubMed] [Google Scholar]
  18. Nelson F. K., Greiner D. L., Shultz L. D., Rajan T. V. The immunodeficient scid mouse as a model for human lymphatic filariasis. J Exp Med. 1991 Mar 1;173(3):659–663. doi: 10.1084/jem.173.3.659. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Reed S. L., Sargeaunt P. G., Braude A. I. Resistance to lysis by human serum of pathogenic Entamoeba histolytica. Trans R Soc Trop Med Hyg. 1983;77(2):248–253. doi: 10.1016/0035-9203(83)90083-4. [DOI] [PubMed] [Google Scholar]
  20. SWARTZWELDER J. C., AVANT W. H. Immunity to amebic infection in dogs. Am J Trop Med Hyg. 1952 Jul;1(4):567–575. doi: 10.4269/ajtmh.1952.1.567. [DOI] [PubMed] [Google Scholar]
  21. Salata R. A., Ravdin J. I. Review of the human immune mechanisms directed against Entamoeba histolytica. Rev Infect Dis. 1986 Mar-Apr;8(2):261–272. doi: 10.1093/clinids/8.2.261. [DOI] [PubMed] [Google Scholar]
  22. Schaible U. E., Wallich R., Kramer M. D., Museteanu C., Simon M. M. A mouse model for Borrelia burgdorferi infection: pathogenesis, immune response and protection. Behring Inst Mitt. 1991 Feb;(88):59–67. [PubMed] [Google Scholar]
  23. Sepúlveda B., Tanimoto-tweki M., Calderón P., de la Hoz R. Inducción de inmunidad pasiva antiamibiana en el hamster por la inyección de suero inmune. Arch Invest Med (Mex) 1974;5(Suppl 2):451–456. [PubMed] [Google Scholar]
  24. Stanley S. L., Jr, Becker A., Kunz-Jenkins C., Foster L., Li E. Cloning and expression of a membrane antigen of Entamoeba histolytica possessing multiple tandem repeats. Proc Natl Acad Sci U S A. 1990 Jul;87(13):4976–4980. doi: 10.1073/pnas.87.13.4976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Tsutsumi V., Mena-Lopez R., Anaya-Velazquez F., Martinez-Palomo A. Cellular bases of experimental amebic liver abscess formation. Am J Pathol. 1984 Oct;117(1):81–91. [PMC free article] [PubMed] [Google Scholar]
  26. Walsh J. A. Problems in recognition and diagnosis of amebiasis: estimation of the global magnitude of morbidity and mortality. Rev Infect Dis. 1986 Mar-Apr;8(2):228–238. doi: 10.1093/clinids/8.2.228. [DOI] [PubMed] [Google Scholar]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

RESOURCES